The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Elizabeth A Stewart - One of the best experts on this subject based on the ideXlab platform.
-
what factors currently limit magnetic resonance guided focused ultrasound of leiomyomas a survey conducted at the first international symposium devoted to clinical magnetic resonance guided focused ultrasound
Fertility and Sterility, 2010Co-Authors: Andrei F Taran, Gina K Hesley, Krzysztof R Gorny, Elizabeth A StewartAbstract:Objective To see if clinicians' impressions were influenced by expert opinion on patient selection criteria that influence magnetic resonance–guided focused ultrasound (MRgFUS) leiomyoma treatment. Design Survey-based study. Setting First international symposium devoted to MRgFUS, "MRgFUS 2008," October 6–7, 2008, Washington, DC. Intervention(s) Questionnaires on fibroid treatment were distributed to attending practitioners before and after the symposium. Main Outcome Measure(s) Selection criteria, which could be considered to be limitations to focused ultrasound therapy, were assessed on a 10-point Likert scale ranging from 1, which indicated no impediment to therapy, to 10, which represented an absolute contraindication to therapy. Result(s) A total of 12 paired pre- and post-symposium questionnaires were analyzed. Mild adenomyosis, heavy bleeding, and bulk complaint were viewed as least likely to be an impediment to therapy both before and after the symposium. The presence of severe adenomyosis and five or more fibroids showed significant increases in mean rankings as contraindications to therapy following the symposium. Significant adverse events not previously reported were elicited by the survey. Conclusion(s) Expert opinion on patient selection criteria for MRgFUS is a useful resource for practitioner education.
Shinji Oikawa - One of the best experts on this subject based on the ideXlab platform.
-
life style and cancer the open symposium of the japanese environmental mutagen society jems in 2015
Genes and Environment, 2016Co-Authors: Hiroyuki Kamiya, Shinji OikawaAbstract:The Open Symposium of the Japanese Environmental Mutagen Society (JEMS), entitled “Life Style and Cancer”, was held at the Shiba-Kyoritsu campus of Keio University, Tokyo, on May 30, 2015. The major aim of this symposium was to provide information about the relationships between lifestyle habits and cancers and an opportunity to inform a wide range of people about the JEMS activities.
Shuichi Masuda - One of the best experts on this subject based on the ideXlab platform.
-
research on environmental mutagenesis from young scientists the open symposium of the japanese environmental mutagen society jems in 2017
Genes and Environment, 2017Co-Authors: Kenichi Masumura, Shuichi MasudaAbstract:The open symposium of the Japanese Environmental Mutagen Society (JEMS) titled, “Research on Environmental Mutagenesis from Young Scientists,” was held at Kokusai Kenkyu Koryu Kaikan, the Foundation for Promotion of Cancer Research, in Tokyo on June 10, 2017. The aim of this symposium was to provide an opportunity to present the research activities of young scientists in the important field of environmental mutagenesis and genetic toxicology and inform JEMS activities to the participants. The organizers reported the symposium summary.
Akira Sassa - One of the best experts on this subject based on the ideXlab platform.
-
challenges of young scientists at the cutting edge of genotoxicity research the open symposium of the japanese environmental mutagen society jems 2018
Genes and Environment, 2018Co-Authors: Manabu Yasui, Shigeharu Muto, Akira SassaAbstract:The Open Symposium of the Japanese Environmental Mutagen Society (JEMS) entitled “Challenges of Young Scientists at the Cutting-edge of Genotoxicity Research” was held in the Main Conference Room of the Foundation for Promotion of Cancer Research, Tokyo, on June 9th, 2018. This year, the symposium aimed to provide an opportunity to highlight the cutting-edge research activities of young scientists who are continuing to expand frontiers of the fields of environmental mutagenesis and genetic toxicology; it also aimed to inform JEMS activities to the participants. Through this report, the organizers present a summary of the symposium.
Andrei F Taran - One of the best experts on this subject based on the ideXlab platform.
-
what factors currently limit magnetic resonance guided focused ultrasound of leiomyomas a survey conducted at the first international symposium devoted to clinical magnetic resonance guided focused ultrasound
Fertility and Sterility, 2010Co-Authors: Andrei F Taran, Gina K Hesley, Krzysztof R Gorny, Elizabeth A StewartAbstract:Objective To see if clinicians' impressions were influenced by expert opinion on patient selection criteria that influence magnetic resonance–guided focused ultrasound (MRgFUS) leiomyoma treatment. Design Survey-based study. Setting First international symposium devoted to MRgFUS, "MRgFUS 2008," October 6–7, 2008, Washington, DC. Intervention(s) Questionnaires on fibroid treatment were distributed to attending practitioners before and after the symposium. Main Outcome Measure(s) Selection criteria, which could be considered to be limitations to focused ultrasound therapy, were assessed on a 10-point Likert scale ranging from 1, which indicated no impediment to therapy, to 10, which represented an absolute contraindication to therapy. Result(s) A total of 12 paired pre- and post-symposium questionnaires were analyzed. Mild adenomyosis, heavy bleeding, and bulk complaint were viewed as least likely to be an impediment to therapy both before and after the symposium. The presence of severe adenomyosis and five or more fibroids showed significant increases in mean rankings as contraindications to therapy following the symposium. Significant adverse events not previously reported were elicited by the survey. Conclusion(s) Expert opinion on patient selection criteria for MRgFUS is a useful resource for practitioner education.
